Una comparación sistemática de la terapia combinada con FAME y la terapia de necrosis tumoral inhibidor con metotrexato en pacientes con artritis reumatoide temprana

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2011
Cargando información sobre las referencias

CRD SUMMARY:

This review concluded that there was strong evidence in support of disease-modifying antirheumatic drug therapies and tumour necrosis factor inhibitors plus methotrexate compared with methotrexate monotherapy, in patients with early rheumatoid arthritis. Although the data appeared to support these findings, concerns over the review methodology and variation between studies suggest that the conclusions should be interpreted with caution.
Epistemonikos ID: 0a79ad0973e14c5b19b0043d0787fade66603bad
First added on: Jun 08, 2012